Demographic features of patients followed up in COVID intensive care units during the pandemic period
Keywords:COVID-19, Pandemic, Intensive Care Unit
Aim: Coronavirus disease is the third coronavirus infection defined in the world in the 21st century, after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS).
Material and Method: We planned to evaluate demographic characteristics retrospectively and present them to the literature with statistical data. The patients included in our study, positive PCR ( polymerase chain reaction) test, who is under treatment in the COVID-19 intensive care units of our hospital due to COVID-19 disease. Age, comorbid conditions, admission complaints, physical examination findings, acute phase reactants, tomography results, length of hospital stay, and treatments of these patients were scanned from the patient files.
Results: Demographic characteristics were found to be similar to the literature, but there is not enough data in the literature about chronic drug use. Elderly age, cardiovascular diseases, and ıntensive care unit hospitalization were associated with mortality.
Conclusion: The patient group who has a chronic disease and uses multiple drugs should be considered. We think that we contribute to the literature with this information in our study.
Morens DM, Daszak P, Taubenberger JK. Escaping Pandora’s box-another novel coronavirus. N Engl J Med 2020; 382: 1293-5.
Dünya Sağlık Örgütü (DSÖ) (2020). WHO Coronavirus Disease (COVID-19) Dashboard, https://covid19.who.int, Erişim tarihi:
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395: 497-506.
Auld SC, Caridi-Scheible M, Blum JM, et al. ICU and ventilator mortality among critically Ill adults with Coronavirus disease 2019. Crit Care Med 2020; 48: 799-804.
Rita L, Raili Suojaranta-Y, Sari K. One-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute
respiratory failure. Crit Care 2010; 14: R60.
T.C. Sağlık Bakanlığı Halk Sağlığı Genel Müdürlüğü COVID-19 (SARSCoV- 2 Enfeksiyonu) Rehberi, 14 Nisan 2020. Available from: https://covid19bilgi.saglik.gov.tr.
Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72314 cases from the Chinese center for disease control and prevention. JAMA 2020; 323: 1239-42.
Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 2020; 395: 507-13.
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-62.
Aldo P, Antonella T, Giuseppe T, and Massimo C. COPD influences survival in patients affected by COVID‐19, comparison between subjects admitted to an internal medicine unit, and subjects admitted to an intensive care unit: An Italian experience. J Med Virol 2021; 93: 1239-41.
Karakoç, Z. Ç, Pınarbaşı-Şimşek B, Asil R. et al. COVID-19 Pandemisinde Birinci Dalga: Tek Merkez Deneyimi. Klimik J/Klimik Derg 2020; 33: 223-9.
Tobaiqy M, Qashqary M, Al-Dahery S et al. Therapeutic management of patients with COVID-19: A systematic review. Infect Prev Pract 2020; 2: 100061.
Eduardo Kaiser Ururahy Nunes F, Bruna Melo Coelho L, Daniel Giunchetti S. Evaluation of the RSNA and CORADS classifications for
COVID-19 on chest computed tomography in the Brazilian population. Clinics (Sao Paulo) 2021; 76: e2476.
Filatov A, Sharma P, Hindi F. et al. Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy. Cureus 2020; 12: e7352.
Faconti L, Chowienczky PJ, Shah AM. Cardiovacular disease, heart failure and COVID-19. J Renin Angiotensin Aldosterone Syst 2020; 21: 1-3.
Pal R, Bhansali A. COVID-19, diabetes mellitus and ACE2: The conundrum. Diabetes Res Clin Pract 2020; 162: 108132.
Wang W, Lu J, Gu W, et al. Care for diabetes with COVID-19: Advice from China. J Diabetes 2020; 12: 417-9.
How to Cite
Copyright (c) 2022 Kastamonu Medical Journal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.